The Journal of Practical Medicine ›› 2026, Vol. 42 ›› Issue (8): 1347-1353.doi: 10.3969/j.issn.1006-5725.2026.08.006
• Chronic Disease Control • Previous Articles
Cuixiao MIAO,Kaiting CHEN(
),Xiaoqing ZHANG,Mi TAN,Xueqin DONG,Yanrong AN,Hui ZHU
Received:2026-01-12
Online:2026-04-25
Published:2026-04-28
Contact:
Kaiting CHEN
E-mail:94004434@qq.com
CLC Number:
Cuixiao MIAO,Kaiting CHEN,Xiaoqing ZHANG,Mi TAN,Xueqin DONG,Yanrong AN,Hui ZHU. The levels of miR-155, miR-31-5p, Aasprosin and GSK-3β predict the risk of osteoporosis in patients with type 2 diabetes[J]. The Journal of Practical Medicine, 2026, 42(8): 1347-1353.
Tab.2
Single factor analysis of T2DM complicated with OP"
| 指标 | T2DM-OP组 (n = 54) | T2DM非OP组 (n = 104) | χ2 /t值 | P值 |
|---|---|---|---|---|
| 年龄/岁 | 74.66 ± 8.61 | 65.97 ± 7.12 | 6.765 | < 0.001 |
| HbA1C/% | 9.41 ± 1.36 | 7.99 ± 0.93 | 7.730 | < 0.001 |
体质量指数/ (kg/m2) | 23.05 ± 2.36 | 22.86 ± 2.29 | 0.490 | 0.625 |
| 病程/年 | 10.82 ± 3.54 | 7.12 ± 2.72 | 7.296 | < 0.001 |
| 性别/[例(%)] | 0.195 | 0.659 | ||
| 男 | 29(53.70) | 52(50.93) | ||
| 女 | 25(46.30) | 52(49.07) | ||
| 吸烟/[例(%)] | 33(61.11) | 31(29.81) | 14.453 | < 0.001 |
| 饮酒/[例(%)] | 35(64.81) | 36(34.62) | 13.101 | < 0.001 |
OP家族史/ [例(%)] | 7(12.96) | 12(11.54) | 0.068 | 0.794 |
T2DM家族史/ [例(%)] | 9(16.67) | 15(14.42) | 0.139 | 0.709 |
| miR-155 | 1.48 ± 0.40 | 1.07 ± 0.32 | 6.999 | < 0.001 |
| miR-31-5p | 0.41 ± 0.12 | 0.64 ± 0.21 | 7.436 | < 0.001 |
| Asprosin/(ng/mL) | 0.98 ± 0.28 | 0.69 ± 0.22 | 7.143 | < 0.001 |
| GSK-3β/(μg/L) | 55.82 ± 16.32 | 37.21 ± 9.96 | 12.235 | < 0.001 |
Tab.4
Multivariate analysis of T2DM complicated with OP"
| 变量 | β | SE | Waldχ2 | P值 | OR | 95%CI | VIF |
|---|---|---|---|---|---|---|---|
| 年龄 | 0.668 | 0.216 | 9.564 | 0.002 | 1.950 | 1.277 ~ 2.978 | 3.129 |
| HbA1C | 0.629 | 0.185 | 11.560 | 0.001 | 1.876 | 1.305 ~ 2.696 | 2.801 |
| 病程 | 0.747 | 0.253 | 8.718 | 0.003 | 2.111 | 1.285 ~ 3.466 | 3.532 |
| 吸烟 | 0.697 | 0.208 | 11.229 | 0.001 | 2.008 | 1.336 ~ 3.018 | 2.117 |
| 饮酒 | 0.646 | 0.197 | 10.753 | 0.001 | 1.908 | 1.297 ~ 2.807 | 3.684 |
| miR-155 | 0.694 | 0.202 | 11.804 | 0.001 | 2.002 | 1.347 ~ 2.974 | 2.753 |
| miR-31-5p | 0.701 | 0.211 | 11.038 | 0.001 | 2.016 | 1.333 ~ 3.048 | 3.561 |
| Asprosin | 0.584 | 0.198 | 8.700 | 0.003 | 1.793 | 1.216 ~ 2.643 | 2.894 |
| GSK-3β | 0.671 | 0.198 | 11.485 | 0.001 | 1.956 | 1.327 ~ 2.884 | 2.169 |
Tab.5
The diagnostic efficacy"
| 指标 | 截断值 | AUC | 95%CI | P值 | 敏感度/% | 特异度/% |
|---|---|---|---|---|---|---|
| 年龄 | 69.50 | 0.805* | 0.734 ~ 0.877 | < 0.001 | 81.50 | 66.30 |
| HbA1C* | 8.94 | 0.778* | 0.693 ~ 0.864 | < 0.001 | 64.80 | 88.50 |
| 病程 | 9.98 | 0.829* | 0.762 ~ 0.895 | < 0.001 | 72.20 | 81.70 |
| 吸烟 | 0.50 | 0.657* | 0.565 ~ 0.748 | 0.001 | 61.10 | 70.20 |
| 饮酒 | 0.50 | 0.651* | 0.560 ~ 0.742 | 0.002 | 64.80 | 65.40 |
| miR-155 | 1.32 | 0.776* | 0.698 ~ 0.853 | < 0.001 | 66.70 | 78.80 |
| miR-31-5p | 0.48 | 0.759* | 0.683 ~ 0.834 | < 0.001 | 70.40 | 72.10 |
| sprosin/(ng/mL)* | 0.90 | 0.803* | 0.722 ~ 0.884 | < 0.001 | 70.40 | 86.50 |
| GSK-3β/(μg/L) | 50.59 | 0.788* | 0.706 ~ 0.870 | < 0.001 | 61.10 | 86.50 |
| 联合 | 0.899 | 0.848 ~ 0.949 | < 0.001 | 81.50 | 86.50 |
| [1] |
詹媛媛, 许馨月, 逯博文, 等. 老年2型糖尿病患者认知障碍与抑郁的相关性研究[J]. 中华老年心脑血管病杂志, 2025, 27(4): 426-430. doi:10.3969/j.issn.1009-0126.2025.04.007 .
doi: 10.3969/j.issn.1009-0126.2025.04.007 |
| [2] |
HENNEY A E, RILEY D R, O'CONNOR B, et al. Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis[J]. Diabetes Obes Metab, 2024, 26(9): 3673-3683. doi: 10.1111/dom.15708 .
doi: 10.1111/dom.15708 |
| [3] |
VILACA T, EASTELL R. Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes[J]. Curr Osteoporos Rep, 2024, 22(1): 1-10. doi: 10.1007/s11914-023-00833-3 .
doi: 10.1007/s11914-023-00833-3 |
| [4] |
潘俊曦, 田天照, 刘保新, 等. 随机森林算法预测绝经后骨质疏松症与2型糖尿病关联microRNA及其靶向基因调控作用[J]. 中国骨质疏松杂志, 2022, 28(2): 248-254. doi:10.3969/j.issn.1006-7108.2022.02.017 .
doi: 10.3969/j.issn.1006-7108.2022.02.017 |
| [5] |
GAO Z, LI Y, ZHANG Y, et al. Salvianolic Acid B Accelerates Osteoporotic Fracture Healing via LncRNA-MALAT1/miR-155-5p/HIF1A Axis[J]. Curr Stem Cell Res Ther, 2025, 20(7): 759-767. doi: 10.2174/011574888X304709240628092958 .
doi: 10.2174/011574888X304709240628092958 |
| [6] |
FANG R, CAO X, ZHU Y, et al. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9[J]. Autoimmunity, 2022, 55(4): 254-263. doi: 10.1080/08916934.2022.2037128 .
doi: 10.1080/08916934.2022.2037128 |
| [7] |
李伟, 项芬芬, 陈思萍, 等. Asprosin在2型糖尿病合并骨质疏松患者中的变化及其与TLR4/JNK/IL-1β通路的关系[J]. 中国骨质疏松杂志, 2024, 30(1): 32-36. doi:10.3969/j.issn.1006-7108.2024.01.007 .
doi: 10.3969/j.issn.1006-7108.2024.01.007 |
| [8] |
LAOHAJAROENSOMBAT O, POOCHANASRI M, SAMAKKARNTHAI P. An update on bone in diabetes[J]. Curr Opin Endocrinol Diabetes Obes, 2025, 32(4): 142-148. doi: 10.1097/MED.0000000000000915 .
doi: 10.1097/MED.0000000000000915 |
| [9] |
尹经霞, 余丽, 蒲丹岚, 等. 《中国糖尿病防治指南(2024版)》解读[J]. 重庆医科大学学报, 2025, 50(5): 557-564. doi:10.13406/j.cnki.cyxb.003749 .
doi: 10.13406/j.cnki.cyxb.003749 |
| [10] |
中华医学会放射学分会骨关节学组, 中国医师协会放射医师分会肌骨学组, 中华医学会骨科学分会骨质疏松学组, 等. 骨质疏松的影像学与骨密度诊断专家共识[J]. 中国骨质疏松杂志, 2020, 26(9): 1249-1256. doi:10.3969/j.issn.1006-7108.2020.09.001 .
doi: 10.3969/j.issn.1006-7108.2020.09.001 |
| [11] | 中华人民共和国卫生部医政司. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社, 2006: 126-137. |
| [12] |
常乐, 周丹微, 顾小琼. 骨质疏松症患者血清DKK-1、CTRP3水平对胸腰椎骨折的预测效能[J]. 实用医学杂志, 2025, 41(12): 1907-1912. doi:10.3969/j.issn.1006-5725.2025.12.020 .
doi: 10.3969/j.issn.1006-5725.2025.12.020 |
| [13] |
LI S, LI W, CHANG L, et al. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes[J]. J Bone Miner Metab, 2024, 42(3): 361-371. doi: 10.1007/s00774-024-01511-9 .
doi: 10.1007/s00774-024-01511-9 |
| [14] |
SON O. Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes[J]. Pak J Med Sci, 2023, 39(5): 1238-1242. doi: 10.12669/pjms.39.5.7580 .
doi: 10.12669/pjms.39.5.7580 |
| [15] |
HOU X, XING B, ZHANG G, et al. Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis[J]. Curr Protein Pept Sci, 2023, 24(4): 355-363. doi: 10.2174/1389203724666230228140808 .
doi: 10.2174/1389203724666230228140808 |
| [16] |
CHEN Y, MIAO Y, ZHANG Q. Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes[J]. Osteoporos Int, 2024, 35(8): 1441-1449. doi: 10.1007/s00198-024-07126-0 .
doi: 10.1007/s00198-024-07126-0 |
| [17] |
RATHMANN W, KOSTEV K. Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: A primary care cohort study[J]. Osteoporos Int, 2024, 35(12): 2099-2106. doi: 10.1007/s00198-024-07182-6 .
doi: 10.1007/s00198-024-07182-6 |
| [18] |
MONAEI K AL, ROBERT A A, FARGHALY H, et al. Assessment of risk factors for bone fractures in patients with type 2 diabetes mellitus: A study in Saudi Arabia[J]. Diabetes Metab Syndr, 2021, 15(3): 955-961. doi: 10.1016/j.dsx.2021.04.008 .
doi: 10.1016/j.dsx.2021.04.008 |
| [19] |
王振, 郭炼锦, 梁嘉荣, 等. 骨质疏松症患者MRI脂肪定量参数联合25-羟基维生素D预测骨折风险的价值[J].实用医学杂志, 2024, 40(22): 3238-3243. doi:10.3969/j.issn.1006-5725.2024.22.020 .
doi: 10.3969/j.issn.1006-5725.2024.22.020 |
| [20] |
CIVIT-URGELL A, PEÑA E, BEJAR M T, et al. bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile[J]. Diabetologia, 2025, 68(12): 2682-2695. doi: 10.1007/s00125-025-06533-0 .
doi: 10.1007/s00125-025-06533-0 |
| [21] |
RAFIEE M, SADEGHI F, MIRZAPOUR A, et al. Association of MicroRNA-103 expression with type 2 diabetes mellitus[J]. Caspian J Intern Med, 2024, 16(1): 106-113. doi: 10.22088/cjim.16.1.106 .
doi: 10.22088/cjim.16.1.106 |
| [22] |
TALEBI S S, REZAIE S, HAJMIRI M S, et al. Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397(11): 9149-9165. doi: 10.1007/s00210-024-03219-z .
doi: 10.1007/s00210-024-03219-z |
| [23] |
FATIMA S, ABRAR M, SHAHID A, et al. Serum asprosin and its association with bone mineral density, oxidative stress, and osteoprotegerin levels in Pakistani women with postmenopausal osteoporosis[J]. Expert Rev Endocrinol Metab, 2025, 20(5): 427-439. doi: 10.1080/17446651.2025.2510595 .
doi: 10.1080/17446651.2025.2510595 |
| [24] |
ZHOU C, HU G, LI Y, et al. Polydatin accelerates osteoporotic bone repair by inducing the osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells via the PI3K/AKT/GSK-3β/β-catenin pathway[J]. Int J Surg, 2025, 111(1): 411-425. doi: 10.1097/JS9.0000000000002075 .
doi: 10.1097/JS9.0000000000002075 |
| [25] |
YANG Y, ZHOU H, WANG Y, et al. Phillygenin Improves the Focal Adhesion Kinase/Glycogen Synthase Kinase 3β/β-Catenin Axis to Promote Mesenchymal Stem Cell Osteogenic Differentiation[J]. Phytother Res, 2025, 39(11): 4991-5005. doi: 10.1002/ptr.8519 .
doi: 10.1002/ptr.8519 |
| [26] |
ROOMI A B, ALI E A, NORI W, et al. Asprosin is a Reliable Predictor of Osteoporosis in Type 2 Diabetic Postmenopausal Women: A Case-Control Study[J]. Indian J Clin Biochem, 2025, 40(1): 97-104. doi: 10.1007/s12291-023-01163-y .
doi: 10.1007/s12291-023-01163-y |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||

